| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/04/2006 | CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 10/04/2006 | CN1277829C 3, 5-disubstituted-oxazolidine with antibiotic activity, its preparation method and use |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115658 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 10/03/2006 | US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents |
| 10/03/2006 | US7115643 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity |
| 10/03/2006 | US7115640 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115617 Anticarcinogenic and kinase inhibitor; a heteroaryl(containing atleast one oxygen or sulfur atom)amino substituted pyrimidine compound |
| 10/03/2006 | US7115612 Arylsulfonamides as antiviral agents |
| 10/03/2006 | US7115610 Substituted heterocyclic compounds |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115596 Thiazole compounds as integrin receptor antagonists derivatives |
| 10/03/2006 | CA2474211C Antiproliferative quinazolines |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 10/03/2006 | CA2247946C Anticachectic composition |
| 10/03/2006 | CA2187130C Novel sulphonamides |
| 09/28/2006 | WO2006101860A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | WO2006101828A1 Insecticidal alkylamino phenyl sulfonamide derivatives |
| 09/28/2006 | WO2006101307A1 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006101108A1 Novel cyclic aminophenylalkanoic acid derivative |
| 09/28/2006 | WO2006101105A1 Agent for treatment of psoriasis |
| 09/28/2006 | WO2006101104A1 Agent for treatment of arthritis |
| 09/28/2006 | WO2006101103A1 Agent for treatment of hematopoietic tumor |
| 09/28/2006 | WO2006101102A1 Agent for treatment of solid tumor |
| 09/28/2006 | WO2006100081A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | WO2006100080A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | WO2006099735A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 09/28/2006 | WO2006078992A3 Heteroaryl substituted piperazinyl-pyridine analogues |
| 09/28/2006 | WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | WO2006025979A3 Modulators of nuclear receptors |
| 09/28/2006 | WO2006012577A3 Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| 09/28/2006 | WO2005119315A3 Non-linear optically active molecules, their synthesis, and use |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217427 Cytoskeletal active compounds, compositions and use |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217390 Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217377 Quinazolines useful as modulators of ion channels |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | CA2602559A1 Agent for treatment of hematopoietic tumor |
| 09/28/2006 | CA2602397A1 Therapeutic agent for solid tumor |
| 09/28/2006 | CA2602174A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2601523A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | CA2601424A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2600074A1 Novel cyclic aminophenylalkanoic acid derivative |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1421078B1 Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1381596B1 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839131A Azolidinecarbonitriles and their use as DPP-IV inhibitors |
| 09/27/2006 | CN1839128A Mitotic kinesin inhibitors |
| 09/27/2006 | CN1839126A Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/27/2006 | CN1838953A 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 09/27/2006 | CN1838890A Corrective clothes with liner |
| 09/27/2006 | CN1276920C Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/26/2006 | US7112683 Cyclic sulfone containing retroviral protease inhibitors |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/26/2006 | US7112598 κ opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/26/2006 | US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 09/26/2006 | US7112553 Particularly isothiazolylamino- or pyridinylamino- substituted; e.g., N-[2-ethoxymethyl-4-chloro-3-methylisothiazolin-5-ylidene]-[2-(2-methylpropyl)indazol-5-yl)acetamide and N-(4-chloro-3-methylisothiazol-5-yl)-N-(ethoxymethyl)-(2-propylbenzotriazol-5-yl)acetamide |
| 09/26/2006 | US7112413 Improved enzymatically-cleavable, chemiluminescent 1,2-dioxetanes containing enzymatically removable labile groups which allows decomposition; qualitative and quantitative analysis for bioassays; half life; kinetics |
| 09/21/2006 | WO2006099474A1 'n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites |
| 09/21/2006 | WO2006099452A1 Anhydrous ziprasidone mesylate and a process for its preparation |
| 09/21/2006 | WO2006099379A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 09/21/2006 | WO2006098834A2 Crystalline forms of ziprasidone mesylate |
| 09/21/2006 | WO2006098128A1 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006079556A3 Substituted 5-phenyl pyrimidines i in therapy |
| 09/21/2006 | WO2006046734A3 Novel aminopyridine derivatives having selective aurora-a inhibitory effect |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | US20060211861 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211735 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 09/21/2006 | US20060211708 Ziprasidone free from colored impurities and a process for its preparation |
| 09/21/2006 | US20060211705 a protein tyrosine kinase inhibitor; useful in the treatment of immunologic and oncological diseases; 2-(6-chloro-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-(hydroxymethyl)phenyl)thiazole-5-carboxamide |